XML 17 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities    
Net income $ 14,415 $ 16,486
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 11,838 8,521
Stock-based compensation 4,467 4,809
Amortization of premium on marketable securities and deferred financing costs 235 122
Earnings of equity method investments (1,772) (2,180)
Deferred income tax benefit (7,682) (689)
Other gains on disposals of assets 6  
Changes in operating assets and liabilities, net of acquisitions:    
Accounts receivable (13,826) (16,157)
Inventories (12,260) (5,518)
Prepaid expenses and other assets 1,029 3,285
Accounts payable 7,932 4,449
Deferred revenue 6,385 1,376
Accrued warranty and retrofit costs 572 87
Accrued compensation and tax withholdings (13,842) (11,145)
Accrued restructuring costs (181) (592)
Accrued expenses and other liabilities 8,948 362
Net cash provided by operating activities 6,264 3,216
Cash flows from investing activities    
Purchases of property, plant and equipment (3,560) (2,700)
Purchases of marketable securities (1,290) (26,875)
Sales of marketable securities 48,904  
Maturities of marketable securities 2,557 100
Acquisitions, net of cash acquired (445,210) (65,074)
Proceeds from sales of property, plant and equipment   200
Net cash used in investing activities (398,599) (94,349)
Cash flows from financing activities    
Proceeds from term loan 340,540 197,554
Payment of deferred financing costs   (318)
Repayment of term loan (1,789)  
Payment of capital lease (121)  
Common stock dividends paid (7,208) (7,057)
Net cash provided by financing activities 331,422 190,179
Effects of exchange rate changes on cash and cash equivalents (1,004) 1,671
Net increase (decrease) in cash and cash equivalents (61,917) 100,717
Cash and cash equivalents, beginning of period 197,708 101,622
Cash and cash equivalents, end of period 135,791 202,339
Supplemental disclosure of non-cash investing and financing activities:    
Purchases of property, plant and equipment included in accounts payable 1,717 865
Deferred financing costs included in accounts payable $ 1,750 $ 143